Exelixis
EXEL
#1759
Rank
$12.21 B
Marketcap
$47.03
Share price
2.48%
Change (1 day)
32.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company